AzTrials
AzTrials

ReflexologyNCT07168187

The Effect of Reflexology on Time to Delivery During Induction of Labor

A study testing Reflexology in people with Reflexology and Labor Induction, run by Wolfson Medical Center at 1 site in Israel.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This prospective, randomized controlled trial evaluates the effect of reflexology on maternal anxiety, labor duration, and pain in women undergoing labor induction with an extra-amniotic balloon (EAB). Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
What is being tested?
Reflexology
Could I receive a placebo?
No, everyone receives an active treatment
How many people
92 participants
Where
1 siteIsrael
Study dates
30 Dec 2025to 1 Aug 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age of ≥18 years
  • Gestational age of >37 weeks
  • Vertex presentation
  • Intact membranes
  • Station of the fetus's head < S-4
  • Bishop score of <6.

Who cannot join

  • Patients who had undergone a previous cesarean delivery
  • Patients with a contraindication for vaginal delivery
  • Patients with a known fetal malformation patients undergoing termination of pregnancy.

Trial locations and contacts

1 site in 1 country.

Israel1 site
  • Edith Wolfson Medical Center

    Holon, 6382111

Other trials in Israel

About this study

Official title: The Effect of Reflexology Treatment on Maternal Anxiety During Induction of Labor With an Extra-amniotic Balloon

This prospective, randomized controlled trial evaluates the effect of reflexology on maternal anxiety, labor duration, and pain in women undergoing labor induction with an extra-amniotic balloon (EAB). Eligible participants are women with a singleton, term pregnancy, cephalic presentation, intact membranes, and a Bishop score <6, without prior cesarean delivery or contraindications to vaginal delivery.

Participants will be randomized to two groups: an intervention group receiving reflexology by a certified practitioner following EAB placement, and a control group receiving standard care. Maternal anxiety will be assessed using the State-Trait Anxiety Inventory (STAI) before and after the intervention. Labor duration and pain scores will also be recorded.

The study plans to enroll 84 participants over two years. Reflexology is a safe, non-invasive complementary therapy, and this study aims to determine whether it provides measurable benefits during labor induction.

Read the detailed description

Labor induction is a common obstetric procedure that can be associated with maternal anxiety, pain, and prolonged labor, potentially affecting the birth experience and maternal well-being. Complementary interventions may help reduce these effects and improve patient satisfaction.

Reflexology is a non-invasive therapy involving targeted pressure on specific points of the feet, hands, or ears, which may promote relaxation and reduce stress and pain. Preliminary evidence suggests reflexology can decrease maternal anxiety and labor pain, but high-quality data in the context of mechanically induced labor are limited.

This study evaluates reflexology during labor induced with an extra-amniotic balloon (EAB). Participants will be randomized to receive either reflexology by a trained practitioner after EAB placement or standard care without reflexology. Maternal anxiety, labor duration, pain, and patient satisfaction will be systematically assessed, using validated measures for anxiety and pain, along with routine clinical and neonatal data collected from hospital records.

The study aims to enroll 84 participants over two years. All participants will provide informed consent, and data will be de-identified to ensure privacy. This trial seeks to provide evidence on the efficacy of reflexology as a complementary intervention during labor induction, informing clinical practice and enhancing maternal-centered care.

Being tested
Reflexology
Keywords
induction to delivery time, labor induction, maternal anxiety

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ReflexologyOther

    Reflexology, a complementary therapy rooted in ancient practices, involves applying pressure to specific points on the feet, hands, or ears thought to stimulate nerve pathways, potentially promoting relaxation and reducing stress. Evidence supporting reflexology's role in obstetrics is growing, with studies highlighting its ability to reduce anxiety, alleviate pain, and influence the duration of labor. Moreover, when reflexology was applied during the active phase of labor it was related to a significant reduction in labor pain intensity and improvements in maternal satisfaction.

Study groups in NCT07168187
Study groupRoleWhat they receive
reflexology during induction of laborExperimentalParticipants randomized to this arm will receive a reflexology treatment administered by a certified reflexologist. The session will occur shortly after placement of the extra-amniotic balloon (EAB) for labor induction and before the balloon's spontaneous expulsion or removal at 24 hours. Reflexology will be performed on specific pressure points on the feet, following a standardized protocol intended to reduce maternal anxiety and pain. Participants will also receive routine obstetric care as per institutional protocol.
Receives: Other: Reflexology
Standard careNo interventionParticipants randomized to this arm will receive standard obstetric care for labor induction with an extra-amniotic balloon (EAB) according to the hospital's clinical protocol. No reflexology or sham procedure will be administered. Anxiety and pain assessments will be conducted at comparable time points to those in the intervention group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maternal anxiety during labor as perceived by the validated state-trait anxiety index

    state-trait anxiety index (STAI-S) questionnaire

    Measured: first STAI questionnaire after recruitment and before induction initiation to assess baseline anxiety. Within 2-10 hours of EAB placement she will fill the second STAI form (similar) and delta STAI score will be calculated

Secondary outcomes (18)
  1. Time from Extra-Amniotic Balloon (EAB) placement to balloon expulsion

    The time in hours from the documented placement of the extra-amniotic balloon (EAB) to its spontaneous expulsion from the cervix, recorded by clinical staff or self-reported by the patient. This outcome is used to assess progression of cervical ripening during labor induction. Per developmental protocol, all EABs that do not spontaneously expel within 24 hours will be removed by a physician, and this will be recorded.

    Measured: From the time of EAB placement until the time of balloon expulsion, assessed up to 24 hours after placement.

  2. Time from labor induction to delivery

    Time (in hours) from the initiation of labor induction-defined as the time of extra-amniotic balloon (EAB) placement-to the time of delivery (vaginal or cesarean). This outcome will be used to assess the effect of reflexology on the overall duration of labor after induction.

    Measured: From the time of EAB placement until the time of delivery, assessed up to 72 hours after induction initiation.

  3. rate of vaginal birth within 24 hours from induction

    vaginal birth rate within the first 24 hours from induction initiation in both groups

    Measured: 24 hours from induction initiation to delivery

  4. Pain during labor induction as measured by the Visual Analogue Scale (VAS)

    Maternal perception of pain will be assessed using the Visual Analogue Scale (VAS), a 10 cm horizontal line ranging from 0 to 10, where 0 represents "no pain" and 10 represents "worst imaginable pain." Each participant will report her pain level at two time points:

    1. Baseline (prior to reflexology or standard care), and
    2. After the intervention (reflexology group) or within 2-10 hours after EAB placement (control group).

    The primary pain outcome will be the maximal reported VAS score during the induction process.

    Measured: Baseline before EAB placement and post-intervention or within 2-10 hours after EAB placement.

  5. Mode of delivery

    Mode of delivery categorized as spontaneous vaginal delivery, instrumental vaginal delivery, or cesarean section. Data will be obtained from delivery records.

    Measured: At delivery

  6. Maternal satisfaction with the labor induction experience

    Maternal satisfaction will be assessed using a scale ranging from 1 to 5, where 1 indicates "not satisfied at all" and 5 indicates "maximally satisfied." Participants will rate their satisfaction after the intervention (reflexology or standard care) and before delivery. Higher scores indicate greater satisfaction.

    Measured: up to 1 hour from intervention and prior to delivery

  7. Intrapartum fever

    Occurrence of maternal intrapartum fever, defined as body temperature ≥38.0°C measured during labor.

    Measured: During labor, up to delivery

  8. Manual lysis of placenta

    Need for manual lysis of placenta, defined as manual removal of the placenta following delivery.

    Measured: At delivery

  9. Neonatal birthweight

    Apgar score at 1 and 5 minutes, each ranging from 0 to 10, with higher scores indicating better neonatal condition.

    Measured: At 1 minute and 5 minutes after birth

  10. Umbilical cord pH

    Arterial umbilical cord pH measured immediately after birth.

    Measured: At birth

  11. NICU admission

    Rate of neonates admitted to the Neonatal Intensive Care Unit (NICU).

    Measured: Immediately after birth, assessed through hospitalization period (up to 28 days)

  12. Respiratory distress syndrome (RDS)

    Rate of neonatal respiratory distress syndrome as documented in the neonatal medical record.

    Measured: During initial hospitalization (up to 28 days of life)

  13. Neonatal ventilation

    Rate of neonates on mechanical or non-invasive ventilation support during the newborn's hospitalization.

    Measured: During initial hospitalization (up to 28 days)

  14. Neonatal neurological morbidity

    Rate of neonates with diagnosed neurological complications, including seizures or intraventricular hemorrhage (IVH), during neonatal hospitalization.

    Measured: During initial hospitalization (up to 28 days)

  15. Neonatal hypoglycemia

    Rate of neonates with documented blood glucose <40 mg/dL within the first 24 hours of life.

    Measured: Within first 24 hours after birth

  16. Neonatal blood transfusion

    Rate of neonates requiring blood transfusion during neonatal hospitalization.

    Measured: During neonatal hospitalization (up to 28 days)

  17. Neonatal phototherapy

    Rate of neonates admitted for phototherapy for hyperbilirubinemia.

    Measured: During neonatal hospitalization (up to 28 days)

  18. Neonatal death

    Rate of dead neonates within the first 28 days of life.

    Measured: Up to 28 days after birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Sep 2025
  2. Study start30 Dec 2025
  3. Primary completion7 Jun 2026
  4. Study completion1 Aug 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
92 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07168187
Sponsor's protocol ID
0011-25-WOMC
Status last verified
Sep 2026
First submitted
8 Jun 2025
Last updated
25 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Reflexology in people with Reflexology and Labor Induction, run by Wolfson Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maternal anxiety during labor as perceived by the validated state-trait anxiety index (time frame: first STAI questionnaire after recruitment and before induction initiation to assess baseline anxiety. Within 2-10 hours of EAB placement she will fill the second STAI form (similar) and delta STAI score will be calculated). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in